Skip to main content
Top
Published in: Nutrition & Metabolism 1/2010

Open Access 01-12-2010 | Brief communication

Brief Communication: Sexual dimorphic expression of myostatin and follistatin like-3 in a rat trans-generational under-nutrition model

Authors: Hassendrini N Peiris, Anna P Ponnampalam, Murray D Mitchell, Mark P Green

Published in: Nutrition & Metabolism | Issue 1/2010

Login to get access

Abstract

The detrimental effects of maternal under-nutrition during gestation on fetal development are well known with an increased propensity of metabolic disorders identified in the adult offspring. Understanding exactly how and by which molecular pathways inadequate nutrition can impact upon offspring phenotype is critical and necessary for the development of treatment methods and ultimately prevention of any negative health effects. Myostatin, a negative regulator of muscle development, has recently been shown to effect glucose homeostasis and fat deposition. The involvement of myostatin in glucose metabolism and adipogenesis thus supports its ability to act in the continued alterations to the postnatal phenotype of the offspring. This hypothesis was examined in the current study using a trans-generational gestationally under-nourished rat model exposed to a high-fat (HF) diet post-weaning. The body weight, body fat, plasma glucose and insulin concentrations of the offspring, both male and female, were investigated in relation to the protein expression of myostatin and its main inhibitor; follistatin like-3 (FSTL-3), in skeletal muscle of mature offspring. Sexual dimorphism was clearly evident in the majority of these measures, including myostatin and FSTL-3 expression. Generally males displayed higher (P < 0.05) myostatin precursor and dimer expression than females, which was especially apparent (P < 0.01) in both chow and HF trans-generationally undernourished (UNAD) groups. In females only, myostatin precursor and dimer expression was altered by both trans-generational under-nutrition and postnatal diet. Overall FSTL-3 expression did not differ between sexes, although difference between sexes within certain treatments and diets were evident. Most notably, HF fed UNAD females had higher (P < 0.05) FSTL-3 expression than HF fed UNAD males. The former group also displayed higher (P < 0.01) FSTL-3 expression compared to all other female groups. In summary, myostatin may prove to be a key mediator of the effects of inadequate prenatal nutrition, independently or in combination with a high-fat postnatal diet on offspring phenotype. Consequently, further study of myostatin may provide a novel therapeutic pathway for the treatment of metabolic disorders; however, it is vital that the influence of nutrition and gender should be taken into consideration.
Appendix
Available only for authorised users
Literature
1.
go back to reference Rodgers BD, Garikipati DK: Clinical, agricultural, and evolutionary biology of myostatin: A comparative review. Endocr Rev. 2008, 29: 513-534. 10.1210/er.2008-0003.CrossRef Rodgers BD, Garikipati DK: Clinical, agricultural, and evolutionary biology of myostatin: A comparative review. Endocr Rev. 2008, 29: 513-534. 10.1210/er.2008-0003.CrossRef
2.
go back to reference Lee SJ: Regulation of muscle mass by myostatin. Annu Rev Cell Dev Biol. 2004, 61-86. 10.1146/annurev.cellbio.20.012103.135836. Lee SJ: Regulation of muscle mass by myostatin. Annu Rev Cell Dev Biol. 2004, 61-86. 10.1146/annurev.cellbio.20.012103.135836.
3.
go back to reference McPherron AC, Lawler AM, Lee SJ: Regulation of skeletal muscle mass in mice by a new TGF-β superfamily member. Nature. 1997, 387 (6628): 83-90. 10.1038/387083a0.CrossRef McPherron AC, Lawler AM, Lee SJ: Regulation of skeletal muscle mass in mice by a new TGF-β superfamily member. Nature. 1997, 387 (6628): 83-90. 10.1038/387083a0.CrossRef
4.
go back to reference Mitchell MD, Osepchook CC, Leung K-C, McMahon CD, Bass JJ: Myostatin is a human placental product that regulates glucose uptake. J Clin Endocrinol Metab. 2006, 91: 1434-1437. 10.1210/jc.2005-2361.CrossRef Mitchell MD, Osepchook CC, Leung K-C, McMahon CD, Bass JJ: Myostatin is a human placental product that regulates glucose uptake. J Clin Endocrinol Metab. 2006, 91: 1434-1437. 10.1210/jc.2005-2361.CrossRef
5.
go back to reference Peiris HN, Ponnampalam AP, Mitchell MD, Green MP: Placental expression of myostatin and follistatin-like-3 protein in a model of developmental programming. Am J Physiol Endocrinol Metab. 2010, 298 (4): E854-61. 10.1152/ajpendo.00673.2009.CrossRef Peiris HN, Ponnampalam AP, Mitchell MD, Green MP: Placental expression of myostatin and follistatin-like-3 protein in a model of developmental programming. Am J Physiol Endocrinol Metab. 2010, 298 (4): E854-61. 10.1152/ajpendo.00673.2009.CrossRef
6.
go back to reference Feldman BJ, Streeper RS, Farese RV, Yamamoto KR: Myostatin modulates adipogenesis to generate adipocytes with favorable metabolic effects. Proc Natl Acad Sci USA. 2006, 103: 15675-15680. 10.1073/pnas.0607501103.CrossRef Feldman BJ, Streeper RS, Farese RV, Yamamoto KR: Myostatin modulates adipogenesis to generate adipocytes with favorable metabolic effects. Proc Natl Acad Sci USA. 2006, 103: 15675-15680. 10.1073/pnas.0607501103.CrossRef
7.
go back to reference Zhao B, Wall RJ, Yang J: Transgenic expression of myostatin propeptide prevents diet-induced obesity and insulin resistance. Biochem Biophys Res Commun. 2005, 337: 248-255. 10.1016/j.bbrc.2005.09.044.CrossRef Zhao B, Wall RJ, Yang J: Transgenic expression of myostatin propeptide prevents diet-induced obesity and insulin resistance. Biochem Biophys Res Commun. 2005, 337: 248-255. 10.1016/j.bbrc.2005.09.044.CrossRef
8.
go back to reference Woodall SM, Breier BH, Johnston BM, Gluckman PD: A model of intrauterine growth retardation caused by chronic maternal under-nutrition in the rat: Effects on the somatotrophic axis and postnatal growth. J Clin Endocrinol. 1996, 150: 231-242.CrossRef Woodall SM, Breier BH, Johnston BM, Gluckman PD: A model of intrauterine growth retardation caused by chronic maternal under-nutrition in the rat: Effects on the somatotrophic axis and postnatal growth. J Clin Endocrinol. 1996, 150: 231-242.CrossRef
9.
go back to reference Vickers MH, Breier BH, Cutfield WS, Hofman PL, Gluckman PD: Fetal origins of hyperphagia, obesity, and hypertension and postnatal amplification by hypercaloric nutrition. Am J Physiol Endocrinol Metab. 2000, 279: E83-E87. Vickers MH, Breier BH, Cutfield WS, Hofman PL, Gluckman PD: Fetal origins of hyperphagia, obesity, and hypertension and postnatal amplification by hypercaloric nutrition. Am J Physiol Endocrinol Metab. 2000, 279: E83-E87.
10.
go back to reference Vickers MH, Gluckman PD, Coveny AH, Hofman PL, Cutfield WS, Gertler A, Breier BH, Harris M: Neonatal leptin treatment reverses developmental programming. Endocrinology. 2005, 146: 4211-4216. 10.1210/en.2005-0581.CrossRef Vickers MH, Gluckman PD, Coveny AH, Hofman PL, Cutfield WS, Gertler A, Breier BH, Harris M: Neonatal leptin treatment reverses developmental programming. Endocrinology. 2005, 146: 4211-4216. 10.1210/en.2005-0581.CrossRef
11.
go back to reference Antony N, Bass JJ, McMahon CD, Mitchell MD: Myostatin regulates glucose uptake in BeWo cells. Am J Physiol Endocrinol Metab. 2007, 293: E1296-E1302. 10.1152/ajpendo.00331.2007.CrossRef Antony N, Bass JJ, McMahon CD, Mitchell MD: Myostatin regulates glucose uptake in BeWo cells. Am J Physiol Endocrinol Metab. 2007, 293: E1296-E1302. 10.1152/ajpendo.00331.2007.CrossRef
12.
go back to reference Evseenko DA, Murthi P, Paxton JW, Reid G, Emerald BS, Mohankumar KM, Lobie PE, Brennecke SP, Kalionis B, Keelan JA: The ABC transporter BCRP/ABCG2 is a placental survival factor, and its expression is reduced in idiopathic human fetal growth restriction. FASEB J. 2007, 21: 3592-3605. 10.1096/fj.07-8688com.CrossRef Evseenko DA, Murthi P, Paxton JW, Reid G, Emerald BS, Mohankumar KM, Lobie PE, Brennecke SP, Kalionis B, Keelan JA: The ABC transporter BCRP/ABCG2 is a placental survival factor, and its expression is reduced in idiopathic human fetal growth restriction. FASEB J. 2007, 21: 3592-3605. 10.1096/fj.07-8688com.CrossRef
13.
go back to reference McMahon CD, Popovic L, Jeanplong F, Oldham JM, Kirk SP, Osepchook CC, Wong KWY, Sharma M, Kambadur R, Bass JJ: Sexual dimorphism is associated with decreased expression of processed myostatin in males. Am J Physiol Endocrinol Metab. 2003, 284: E377-E381.CrossRef McMahon CD, Popovic L, Jeanplong F, Oldham JM, Kirk SP, Osepchook CC, Wong KWY, Sharma M, Kambadur R, Bass JJ: Sexual dimorphism is associated with decreased expression of processed myostatin in males. Am J Physiol Endocrinol Metab. 2003, 284: E377-E381.CrossRef
14.
go back to reference Oldham JM, Osepchook CC, Jeanplong F, Falconer SJ, Matthews KG, Conaglen JV, Gerrard DF, Smith HK, Wilkins RJ, Bass JJ, McMahon CD: The decrease in mature myostatin protein in male skeletal muscle is developmentally regulated by growth hormone. J Physiol. 2009, 587: 669-677. 10.1113/jphysiol.2008.161521.CrossRef Oldham JM, Osepchook CC, Jeanplong F, Falconer SJ, Matthews KG, Conaglen JV, Gerrard DF, Smith HK, Wilkins RJ, Bass JJ, McMahon CD: The decrease in mature myostatin protein in male skeletal muscle is developmentally regulated by growth hormone. J Physiol. 2009, 587: 669-677. 10.1113/jphysiol.2008.161521.CrossRef
15.
go back to reference Yamada R, Griggo MA, Luz J: Energy balance of pregnant diabetic rats. Br J Nutr. 2002, 87: 509-515. 10.1079/BJN2001520.CrossRef Yamada R, Griggo MA, Luz J: Energy balance of pregnant diabetic rats. Br J Nutr. 2002, 87: 509-515. 10.1079/BJN2001520.CrossRef
16.
go back to reference Nasu R, Seki K, Nara M, Murakami M, Kohama T: Effect of a high-fat diet on diabetic mother rats and their offspring through three generations. Endocrine J. 2007, 54: 563-569. 10.1507/endocrj.K06-175.CrossRef Nasu R, Seki K, Nara M, Murakami M, Kohama T: Effect of a high-fat diet on diabetic mother rats and their offspring through three generations. Endocrine J. 2007, 54: 563-569. 10.1507/endocrj.K06-175.CrossRef
Metadata
Title
Brief Communication: Sexual dimorphic expression of myostatin and follistatin like-3 in a rat trans-generational under-nutrition model
Authors
Hassendrini N Peiris
Anna P Ponnampalam
Murray D Mitchell
Mark P Green
Publication date
01-12-2010
Publisher
BioMed Central
Published in
Nutrition & Metabolism / Issue 1/2010
Electronic ISSN: 1743-7075
DOI
https://doi.org/10.1186/1743-7075-7-44

Other articles of this Issue 1/2010

Nutrition & Metabolism 1/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.